199 related articles for article (PubMed ID: 34331697)
1. Effects of Curcumin on Depression and Anxiety: A Narrative Review of the Recent Clinical Data.
Khodadadegan MA; Azami S; Guest PC; Jamialahmadi T; Sahebkar A
Adv Exp Med Biol; 2021; 1291():283-294. PubMed ID: 34331697
[TBL] [Abstract][Full Text] [Related]
2. An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial.
Esmaily H; Sahebkar A; Iranshahi M; Ganjali S; Mohammadi A; Ferns G; Ghayour-Mobarhan M
Chin J Integr Med; 2015 May; 21(5):332-8. PubMed ID: 25776839
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial.
Asadi S; Gholami MS; Siassi F; Qorbani M; Sotoudeh G
Phytother Res; 2020 Apr; 34(4):896-903. PubMed ID: 31788880
[TBL] [Abstract][Full Text] [Related]
4. Potential Role of Vitamin D for the Management of Depression and Anxiety.
Casseb GAS; Kaster MP; Rodrigues ALS
CNS Drugs; 2019 Jul; 33(7):619-637. PubMed ID: 31093951
[TBL] [Abstract][Full Text] [Related]
5. Curcumin in antidepressant treatments: An overview of potential mechanisms, pre-clinical/clinical trials and ongoing challenges.
Zhang Y; Li L; Zhang J
Basic Clin Pharmacol Toxicol; 2020 Oct; 127(4):243-253. PubMed ID: 32544307
[TBL] [Abstract][Full Text] [Related]
6. Neuroproteomics: Unveiling the Molecular Insights of Psychiatric Disorders with a Focus on Anxiety Disorder and Depression.
Rodrigues-Ribeiro L; Resende BL; Pinto Dias ML; Lopes MR; de Barros LLM; Moraes MA; Verano-Braga T; Souza BR
Adv Exp Med Biol; 2024; 1443():103-128. PubMed ID: 38409418
[TBL] [Abstract][Full Text] [Related]
7. Clinical Use of Curcumin in Depression: A Meta-Analysis.
Ng QX; Koh SSH; Chan HW; Ho CYX
J Am Med Dir Assoc; 2017 Jun; 18(6):503-508. PubMed ID: 28236605
[TBL] [Abstract][Full Text] [Related]
8. Comorbid anxiety in late-life depression: Relationship with remission and suicidal ideation on venlafaxine treatment.
Saade YM; Nicol G; Lenze EJ; Miller JP; Yingling M; Wetherell JL; Reynolds CF; Mulsant BH
Depress Anxiety; 2019 Dec; 36(12):1125-1134. PubMed ID: 31682328
[TBL] [Abstract][Full Text] [Related]
9. Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study.
Kanchanatawan B; Tangwongchai S; Sughondhabhirom A; Suppapitiporn S; Hemrunrojn S; Carvalho AF; Maes M
Neurotox Res; 2018 Apr; 33(3):621-633. PubMed ID: 29327213
[TBL] [Abstract][Full Text] [Related]
10. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
11. Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance.
Yeung KS; Hernandez M; Mao JJ; Haviland I; Gubili J
Phytother Res; 2018 May; 32(5):865-891. PubMed ID: 29464801
[TBL] [Abstract][Full Text] [Related]
12. Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings.
Kaufmann FN; Gazal M; Bastos CR; Kaster MP; Ghisleni G
Eur J Pharmacol; 2016 Aug; 784():192-8. PubMed ID: 27235294
[TBL] [Abstract][Full Text] [Related]
13. Curcumin in Depression: Potential Mechanisms of Action and Current Evidence-A Narrative Review.
Ramaholimihaso T; Bouazzaoui F; Kaladjian A
Front Psychiatry; 2020; 11():572533. PubMed ID: 33329109
[TBL] [Abstract][Full Text] [Related]
14. Curcumin for depression: a meta-analysis.
Fusar-Poli L; Vozza L; Gabbiadini A; Vanella A; Concas I; Tinacci S; Petralia A; Signorelli MS; Aguglia E
Crit Rev Food Sci Nutr; 2020; 60(15):2643-2653. PubMed ID: 31423805
[TBL] [Abstract][Full Text] [Related]
15. The role of vitamin C in stress-related disorders.
Moritz B; Schmitz AE; Rodrigues ALS; Dafre AL; Cunha MP
J Nutr Biochem; 2020 Nov; 85():108459. PubMed ID: 32745879
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Seltorexant-Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety.
Ziemichód W; Kurowska A; Grabowska K; Kurowska M; Biała G
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110810
[TBL] [Abstract][Full Text] [Related]
17. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
[TBL] [Abstract][Full Text] [Related]
18. Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
Turna J; Patterson B; Van Ameringen M
Depress Anxiety; 2017 Nov; 34(11):1006-1017. PubMed ID: 28636769
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder.
Panahi Y; Badeli R; Karami GR; Sahebkar A
Phytother Res; 2015 Jan; 29(1):17-21. PubMed ID: 25091591
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study.
Lopresti AL; Drummond PD
J Affect Disord; 2017 Jan; 207():188-196. PubMed ID: 27723543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
